ARS Pharmaceuticals, Inc. (SPRY)
(Delayed Data from NSDQ)
$13.33 USD
-0.21 (-1.55%)
Updated Aug 16, 2024 04:00 PM ET
After-Market: $13.36 +0.03 (0.23%) 5:30 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Earnings News For SPRY
-
ARS Pharmaceuticals, Inc. (SPRY) Reports Q2 Loss, Lags Revenue Estimates
-
ARS Pharmaceuticals Provides Business Highlights and Reports Second Quarter 2024 Financial Results
-
ARS Pharmaceuticals, Inc. (SPRY) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
-
ARS Pharmaceuticals Highlights neffy Regulatory Progress and Reports First Quarter 2024 Financial Results
-
ARS Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
-
ARS Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Updates
-
ARS Reports Second Quarter 2023 Financial Results and Provides Business Updates
-
ARS Pharmaceuticals Highlights Progress and Reports First Quarter 2023 Financial Results
-
ARS Pharmaceuticals Highlights Progress and Reports Fourth Quarter and Full Year 2022 Financial Results